• 53,845+ CME Conference Registrations Sold
  • 161,534+ Medical Conferences
  • 285 Specialties
  • 11,614 Organizers
  • 158,539 Speakers
  • 159 Countries
  • 4,829 Cities
Home  >  Conferences  >  4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit

4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit

Oct 14 08:00 AM - Oct 15 04:00 PM, 2020   |   Vienna, Wien  Austria
Organized by : Vonlanthen Group of Companies
Interested
Conference Brochure

4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit is organized by Vonlanthen Group of Companies and will be held from Oct 14 - 15, 2020 at Hilton Garden Inn Vienna South, Vienna, Wien, Austria.

Who Should Attend:
Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:
• Ageing
• ALS
• Alzheimer’s
• Analytical
• Antimicrobials
• Aseptic
• Atherosclerosis
• Autoimmune
• Autologous
• Bacteriology
• Bacteriotherapy
• Biochemistry
• Biofuels
• Bioinformatics
• Biology
• Biomarker
• Biopharmaceutical
• Bioreactors
• Biotechnology
• Bone Marrow Transplantation
• Bowel Syndrome
• Bulk Material
• Cell Biology
• Cell Culture
• CGMP 
• Clinical Development
• Clinical Study
• Clinical Trial
• CMC
• CMO
• CNS
• Commercialisation
• Computational Biology
• Confocal Microscopy
• Contract Manufacturing
• Cytokines
• Delivery
• Diabetes
• Regulatory
• Safety
• Sequencing
• Skin
• Small Molecule
• SOP
• Symbiosys
• Synbiotics
• Synthetic Biology
• Technology Transfer
• Testing
• Tissue Culture
• Translational Sciences
• Ulcerative Colitis
• Vaccines
• Viruses
• Western Blotting
• DNA
• Drug Delivery
• Dysbiosis
• Ecology
• Eligobiotics
• Endocrinology
• Epidemiology
• Faecal Microbiota
• Fermentation
• Filtration
• Flow Cytometry
• FMT
• Freeze Drying
• Fusobacteria
• Gastroenterology
• Gastrointestinal
• Genome Sequencing
• Genomics
• GI
• GMP
• Gut
• Gut-Brain Axis
• High Throughput Screening
• Hypertension
• IBD
• IBS
• ICH
• Immuno-Inflammation
• Immuno-Oncology
• In Vitro
• In Vivo
• IND
• Infectious Disease
• Inflammation
• Intellectual Property
• Invention
• Investment
• Isolation
• Laboratory
• LBPs
• Licensing
• Lifesciences
• Live Biotherapeutics
• Live Cell Therapeutics
• Liver Disease
• Lyophiliser
• Manufacturing
• Medicinal Chemistry
• Mergers & Acquisition
• Metagenomic
• Metatranscriptomics
• Microbiology
• Microbiome
• Microbiota
• Microbiotherapy
• Microorganisms
• Molecular Biology
• Mucosal Immunology
• Multiple Sclerosis
• NASH
• Neurodegenerative
• Nutraceuticals
• Nutrients
• Nutrition
• Obesity
• Oncoviruses
• Patent
• Pathogen
• PCR
• Phages
• Pre-Clinical
• Prebiotics
• Probiotics
• Process Cultivation
• Product Development
• Production
• QA
• Quality Control
• R&D

Description:
This year, our annual Microbiome: Recent Developments, Regulatory, Quality, and Commercialization Summit will take place in a modern city with history at its heart, Vienna. We are very excited to bring you an event dedicated to the best practices and inside views of the future of microbiome-based products concerning the quality, safety, and efficiency.

What are the recommendations for driving efficient strategies within the microbiome landscape? Do you want to know more about the CMC, QA/QC technical perspectives of the microbiome? This and much more in October in Vienna.

About:
The Summit will shed light on current challenges, best practices and inside views of the future of microbiome-based products in relation to quality, safety and efficiency.

We will discuss key findings, critical insights and recommendations for driving efficient strategies within the microbiome landscape.

It is an honour and privilege to invite you to participate in this Summit.

Key Practical Learning Points:
• Emerging tech and developments to bring to the market efficient and safe microbiome products
• Regulatory expectations for probiotics, LBPs, FMTs and emerging microbiome-based medicines
• Critical considerations to translate research and preclinical advancements into clinical trials and next-generation therapeutics
• Identifying early investment opportunities 
• Commercialisation of microbiome-based diagnostics, therapies and services
• CMC, QA/QC technical perspectives for microbiome
• GMP manufacturing and scaleup considerations applicable for microbiome
• Building efficient launch and IP management strategies

Registration Desk

1(800) 828-2059

support@emedevents.com

Registration

Registration Type Last Date Price
Delegate Regular Fee 13 Oct,2020 EUR 1,995.00
Group 2-3 Regular Fee 13 Oct,2020 EUR 1,795.00
Group 4 plus Regular Fee 13 Oct,2020 EUR 1,495.00
Non Profit Regular Fee 13 Oct,2020 EUR 1,495.00
Interested
View Expired Tickets
view all
  • Drive Walk Transit Bicycle

Venue Address

Hilton Garden Inn Vienna South
Hertha-Firnberg-Straße 5
Vienna, Wien, Austria

Official Hotel

Hilton Garden Inn Vienna South,

Hertha-Firnberg-Straße 5,

Vienna, Wien, Austria 1100,

+43 1 60530555

Plan Your Travel

Hotel Dealing
Hotel
Flights
flights
Cars
Rides
Traveller insurance
Traveller insurance

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

The Burgundy Hotel, Tapestry Collection by Hilton
43.88 miles from venue
Price : USD 194.00 Per Night
Little Rock Marriott
40 miles from venue
Price : USD 168.32 Per Night
Close

Session Details

Session Topic Start Time End Time Location Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news